Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial 6G-15-2
An Open-Label, Phase 1/2a Dose Escalation Study of Safety and Efficacy of NEO100 in Recurrent or Progressive Grade III or IV Gliomas with IDH1 Mutation
Type:
Treatment
Phase:
Phase I/II
Status:
Open to Accrual
Treatments:
Other
Randomized:
No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Frances Chow, M.D.
Other Trial Staff:
Sandy Leong, Coordinator, Anush Arakelyan, Coordinator, Aida Lozada, Coordinator
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.